Proteasome inhibitor-associated thrombotic microangiopathy: A review of cases reported to the FDA adverse event reporting system and published in the literature.
Michelle Nadeau NguyenAfrouz NayernamaS Christopher JonesBindu KanapuruNicole GormleyPeter E WaldronPublished in: American journal of hematology (2020)